Phibro Animal Health
PAHC
154 hedge funds and large institutions have $548M invested in Phibro Animal Health in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 67 reducing their positions, and 16 closing their positions.
12% more capital invested
Capital invested by funds: $491M → $548M (+$57.1M)
2.72% more ownership
Funds ownership: 100.11% → 102.83% (+2.7%)
0% more funds holding
Funds holding: 154 → 154 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
31% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 67
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$11.6M |
| 2 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
+$6.43M |
| 3 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$4.75M |
| 4 |
Janus Henderson Group
London,
|
+$3.18M |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$2.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$6.11M |
| 2 |
CSC
Cove Street Capital
El Segundo,
California
|
-$2.43M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$2.19M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.67M |
| 5 |
Goldman Sachs
New York
|
-$1.65M |
PAHC Hedge Fund Activity: Q2 2020 in Review
154 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2020, worth a combined $548M — up 12% from $491M a quarter earlier.
Fund positioning in PAHC was balanced in Q2 2020: 16 funds opened new positions, 16 closed out, 46 added to existing stakes and 67 trimmed.
The largest buyer was Amundi Asset Management US, opening a new position worth an estimated $11.6M. The largest seller was Eagle Asset Management, cutting an estimated $6.11M.
- 154 institutional investors held Phibro Animal Health (PAHC) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $548M of Phibro Animal Health stock for Q2 2020, up 12% quarter-over-quarter.
- 16 funds opened new Phibro Animal Health positions in Q2 2020 and 16 closed out, a net change of 0 holders.
- The largest Phibro Animal Health buyer in Q2 2020 was Amundi Asset Management US, an estimated $11.6M added.
- The largest Phibro Animal Health seller in Q2 2020 was Eagle Asset Management, an estimated $6.11M sold.
Based on aggregated 13F filings for Q2 2020.